Literature DB >> 1885727

Antigenic variation among strains of Chlamydia pneumoniae.

C M Black1, J E Johnson, C E Farshy, T M Brown, B P Berdal.   

Abstract

The antigenic profiles of six strains of Chlamydia pneumoniae were analyzed by the microimmunofluorescence test (MIF) and immunoblotting with human serum and murine monoclonal antibody. MIF-derived antibody titers in serum samples from culture-positive patients were four- to eightfold higher against autologous isolate antigen than they were against the prototype antigen strain TW-183. Sera of patients with respiratory illness that were culture negative and complement fixation positive for Chlamydia spp. produced higher titers by MIF against a strain of C. pneumoniae isolated in the area than they did against TW-183. For two of five cases, the criteria for establishing the diagnosis of acute infection were met only with use of the antigen from the local strain; TW-183 was inadequate for this purpose. Immunoblot profiles revealed antigenic differences between strains that varied with the human serologic response; i.e., unique antigens were recognized by the sera of some individuals and not by the sera of others. Using the reactivity of a genus-specific monoclonal antibody against a major outer membrane protein, we found that strain CWL-011, isolated in Atlanta, Ga., may possess a major outer membrane protein with a molecular mass between those of C. trachomatis L2 and other C. pneumoniae strains. These data provide evidence of several new and unique serotypes of C. pneumoniae and suggest that the serologic diagnosis of C. pneumoniae infection may require the use of antigens from more than one strain of this species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885727      PMCID: PMC270107          DOI: 10.1128/jcm.29.7.1312-1316.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Human serology in Chlamydia trachomatis infection with microimmunofluorescence.

Authors:  S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

2.  Serological response to Chlamydia pneumoniae infection.

Authors:  L A Campbell; C C Kuo; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR).

Authors:  S Ladany; C M Black; C E Farshy; J M Ossewaarde; R C Barnes
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

4.  Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.

Authors:  E Y Chi; C C Kuo; J T Grayston
Journal:  J Bacteriol       Date:  1987-08       Impact factor: 3.490

5.  Structural and antigenic analysis of Chlamydia pneumoniae.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 6.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases.

Authors:  J T Grayston; S P Wang; C C Kuo; L A Campbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

7.  Analysis of the human serological response to proteins of Chlamydia trachomatis.

Authors:  W J Newhall; B Batteiger; R B Jones
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

  8 in total
  24 in total

1.  Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae.

Authors:  T O Messmer; J Martinez; F Hassouna; E R Zell; W Harris; S Dowell; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Evolutionary relationships among members of the genus Chlamydia based on 16S ribosomal DNA analysis.

Authors:  B Pettersson; A Andersson; T Leitner; O Olsvik; M Uhlén; C Storey; C M Black
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Antigenic and molecular analyses of different Chlamydia pneumoniae strains.

Authors:  C A Jantos; S Heck; R Roggendorf; M Sen-Gupta; J H Hegemann
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Contribution of systematic serological testing in diagnosis of infective endocarditis.

Authors:  D Raoult; J P Casalta; H Richet; M Khan; E Bernit; C Rovery; S Branger; F Gouriet; G Imbert; E Bothello; F Collart; G Habib
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

6.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.

Authors:  A Essig; U Simnacher; M Susa; R Marre
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

8.  Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots.

Authors:  H M Freidank; A S Herr; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

9.  Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans.

Authors:  Y Iijima; N Miyashita; T Kishimoto; Y Kanamoto; R Soejima; A Matsumoto
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.